Paragon 28, Inc.

Paragon 28, Inc. (FNA) priced its initial public offering on Oct 18, 2021 at $16.00 per share, raising $125M, and listed on NYSE. At the IPO price its market capitalization was about $1.2B. BofA Securities was lead-left underwriter, joined by Piper Sandler, Canaccord Genuity and Citizens JMP and others. Latham & Watkins advised the company and A&O Shearman advised the underwriters.

Paragon 28, Inc. is a medical device company focused exclusively on the foot and ankle orthopedic market. Its portfolio covers fracture fixation, bunions, hammertoe, flatfoot and other conditions, with surgical implants, disposables and instrumentation.

Status

IPO

Ticker

FNA

Exchange

NYSE

Priced

Oct 18, 2021

IPO price

$16.00

Raised

$125M

Market cap at IPO price

$1.2B

First filed

Sep 24, 2021

Underwriters

BofA Securities, Piper Sandler, Canaccord Genuity, Citizens JMP and Needham

Company counsel

Latham & Watkins

Underwriters' counsel

A&O Shearman

Sector

Healthcare

Country / state

CO

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.